BSG and hepatocellular carcinoma: Indeed, HCC recurrence rate was found to be significantly decreased, and the survival length of HCC patients subjected to liver transplantation prolonged, following the administration of a monoclonal antibody against CD147, in a randomized controlled trial (65).